NCT01410422

Brief Summary

Metabolomics is a large-scale approach to monitoring the compounds involved in cellular processes. It may reflect changes in biological function. Collection of exhaled breath is a newly developed, noninvasive method that may allow clinicians and researchers to assess biochemical profiles in the airway. This study is conducted for the metabolomic analysis of the exhaled gas in patients with Chronic Obstructive Pulmonary Disease (COPD) and bronchiectasis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 5, 2011

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2014

Completed
Last Updated

August 5, 2011

Status Verified

May 1, 2011

First QC Date

August 4, 2011

Last Update Submit

August 4, 2011

Conditions

COPDBronchiectasis

Keywords

COPDBronchiectasisMetabolomics

Study Arms (2)

COPD

COPD

Bronchiectasis

Bronchiectasis

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with COPD and bronchiectasis

You may qualify if:

  • patients with COPD or bronchiectasis

You may not qualify if:

  • not willing to sign ICF

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, Taiwan

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Breath condensate, blood, urine

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveBronchiectasis

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBronchial Diseases

Study Officials

  • Ping-Hung Kuo, M.D.

    National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ping-Hung Kuo

CONTACT

886-972651067Kph712@ntuh.gov.tw

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 4, 2011

First Posted

August 5, 2011

Study Start

May 1, 2011

Study Completion

April 1, 2014

Last Updated

August 5, 2011

Record last verified: 2011-05

Locations

TW(1)